Title: Stroke distribution patterns
and characteristics in Kenya’s leading public
health tertiary institutions: Kenyatta National
Hospital and Moi Teaching and Referral Hospital
Authors: Lydia Kaduka, Anne Korir, Chrispine
Owuor Oduor, Judith Kwasa, Jane Mbui, Sylvanos
Wabwire, Robai Gakunga, Nathan Okerosi, Yvonne
Opanga, Isaac Kisiang’ani, Mercy Rotich
Chepkurui, Erastus Muniu, Scot C Remick
From: Cardiovascular Journal of Africa, Vol 29,
Issue 2, March/April
Published: 2018
Pages: 68-72
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number:10.5830/CVJA-2017-046
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2017-046
IBackground: Cardiovascular diseases are the
second leading cause of morbidity and mortality
in Kenya. However, there is limited
clinico-epidemiological data on stroke to inform
decision making. This study sought to establish
stroke distribution patterns and characteristics
in patients seeking care at Kenyatta National
Hospital (KNH) and Moi Teaching and Referral
Hospital (MTRH), with the ultimate aim of
establishing the first national stroke registry
in Kenya.
Methods: This was a prospective multicentre
cohort study among stroke patients. The study
used a modified World Health Organisation
STEP-wise approach to stroke surveillance tool
in collecting data on incidence, major risk
factors and mortality rate. The Cochran’s
Mantel–Haenszel chisquared test of conditional
independence was used with p-value set at 0.05.
Results: A total of 691 patients with confirmed
stroke were recruited [KNH 406 (males: 40.9%;
females: 59.1%); MTRH 285 (males: 44.6%;
females: 55.4%)] and followed over a 12-month
period. Overall, ischaemic stroke accounted for
55.6% of the stroke cases, with women being the
most affected (57.5%). Mortality rate at day 10
was 18.0% at KNH and 15.5% at MTRH, and higher
in the haemorrhagic cases (20.3%). The most
common vascular risk factors were hypertension
at 77.3% (males: 75.7%; females: 78.5%), smoking
at 16.1% (males: 26.6%; females: 8.3%) and
diabetes at 14.9% (males: 15.7%; females:
14.4%). Ischaemic stroke was conditionally
independent of gender after adjusting for age.
Conclusions: To our knowledge this is the first
pilot demonstration establishing a stroke
registry in sub-Saharan Africa and clearly
establishes feasibility for this approach. It
also has utility to both inform and potentially
guide public policy and public health measures
on stroke in Kenya. Important and unexpected
observations included the preponderance of women
affected by cerebrovascular disease and that
cigarette smoking was the second most common
risk factor. The latter, over time, will further
impact on the clinico-epidemiological profile of
cerebrovascular disease in Kenya.
Title: Prevalence, awareness, treatment and control of hypertension,
diabetes and hypercholesterolaemia among adults in Dande municipality, Angola
Authors: João M Pedro, Miguel Brito, Henrique
Barros
From: Cardiovascular Journal of Africa, Vol 29,
Issue 2, March/April
Published: 2018
Pages: 173–81
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number:10.5830/CVJA-2017-047
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2017-047
Objectives: To estimate the prevalence,
awareness, treatment and control of hypertension, diabetes and
hypercholesterolaemia in an Angolan population aged 15 to 64 years and to
determine relationships with sociodemographic, behavioural and anthropometric
characteristics.
Methods: A total of 2 354 individuals were assessed for behavioural,
sociodemographic and physical characteristics in a cross-sectional,
community-based survey. Post-stratification survey weights were applied to
obtain prevalence levels. Adjusted odds ratios for each variable related to the
conditions were calculated using logistic regression models.
Results: Overall, the prevalence of hypertension was 18.0%, diabetes 9.2% and
hypercholesterolaemia 4.0%. Among hypertensive individuals, the awareness rate
was 48.5%; 15.8% were on treatment and 9.1% had their blood pressure controlled.
Only 10.8% were aware they had diabetes, 4.5% were on treatment and 2.7% were
controlled. The awareness level for hypercholesterolaemia was 4.2%, with 1.4%
individuals on treatment and 1.4% controlled.
Conclusions: The prevalence levels of hypertension and diabetes, which were
higher than previous findings for the region, together with the observed low
rates of awareness, treatment and control of all conditions studied, constitute
an additional challenge to the regional health structures, which must rapidly
adapt to the epidemiological shift occurring in this population.
Title: Assessment of left atrial
function in patients with type 2 diabetes
mellitus with a disease duration of six months
Authors: Oyku Gulmez, Hulya Parildar, Ozlem
Cigerli, Nilgun Demirağ
From: Cardiovascular Journal of Africa, Vol 29,
Issue 2, March/April
Published: 2018
Pages: 82–87
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2017-048
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2017-048
Introduction: Changes in left atrial (LA) size
and function are associated with adverse
clinical events. Recently, duration of diabetes
mellitus (DM2) has been found to be positively
associated with increased LA volume and impaired
LA function. This study was performed, using
two-dimensional echocardiograpy, to evaluate the
changes in LA volume and function in patients
with DM2 with a disease duration of six months,
and to assess the parameters that affect LA
volume and function.
Methods: Fifty-six patients (28 male, age: 52.6
± 6.5 years) with DM2 and 56 controls (24 male;
age: 50.1 ± 7.0 years) were enrolled in the
study. Each subject underwent conventional
twodimensional echocardiography to assess LA
volume (indexed maximal LA volume: Vmax,
pre-atrial contraction volume: Volp, minimal LA
volume: Vmin) and LA function [passive emptying
volume – passive emptying fraction (PEV – PEF),
active emptying volume – active emptying
fraction (AEV – AEF), total emptying volume –
total emptying fraction (TEV – TEF)].
Results: LA diameter, indexed Vmax, Volp, Vmin,
AEV and TEV were found to be significantly
higher in the DM2 group compared with the
controls (p < 0.05). Indexed Vmax, Volp and Vmin
were significantly correlated with HbA1c level,
body mass index (BMI), high-sensitivity
C-reactive protein and uric acid levels, mitral
A wave, E/E′ ratio and A′ wave. According to
multivariate analysis, age and BMI had a
statistically significant effect on LA volume.
Conclusion: Impaired LA function may be present
in patients with newly diagnosed DM2. BMI and
increasing age caused LA enlargement and LA
volumes that were independent of the effects of
hypertension and DM2.
Title: Upper limb ischaemia: a South
African single-centre experience
Authors: Tinus du Toit, Kathryn Manning, Nadraj
G Naidoo
From: Cardiovascular Journal of Africa, Vol 29,
Issue 2, March/April
Published: 2018
Pages: 88–92
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2017-049
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2017-049
Objective: The aims of this study were to report
on our experience with upper limb ischaemia
(ULI), to define the pattern and distribution of
disease, describe key demographic features and
report on conventional clinical outcomes.
Methods: This was a single-centre,
retrospective, descriptive study. All patients
(n = 64) who underwent a surgical intervention
for ULI over a 12-year study period were
included. Findings were analysed and compared
with the current literature.
Results: A male:female ratio of 0.60 was
reported. Two major subgroups of patients were
identified. The patients in the thrombo-embolic
subgroup (n = 30) were notably younger than
expected (mean age 55 years) compared to those
in the atherosclerotic occlusive disease
subgroup (n = 12, mean age 57 years).
Presentation overall was generally late, with
8.6% of acute ULI and 48.3% of chronic ULI
patients presenting with irreversible ischaemia
and tissue loss, respectively. Thrombo-embolism
was the dominant vascular pathology reported in
this case series (47%). Ninety-five procedures
were performed in 64 patients (89 open, six
endovascular). Peri-operative (30-day) mortality
rate was 7.8%. Systemic and procedure-related
complications were observed in 13 and 23%,
respectively. The overall major amputation rate
was 10.9%. Adherence to follow up was poor (51%
at six months).
Conclusion: Although few firm conclusions could
be drawn, this review has expanded our overall
perspective of ULI, specific to the population
we serve. Collaboration between African vascular
units should be encouraged in an attempt to
further define the pattern of ULI by identifying
distinct geographical confounders.
Title: Comparison of carotid intima–media thickness and coronary
artery calcium score for estimating subclinical atherosclerosis in patients with
fatty liver disease
Authors: Hyun-Jin Kim, Hyung-Bok Park, Yongsung
Suh, Yoon-Hyeong Cho, Eui-Seok Hwang, Deok-Kyu Cho, Tae-Young Choi
From: Cardiovascular Journal of Africa, Vol 29,
Issue 2, March/April
Published: 2017
Pages: 93–98
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2017-052
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2017-052
Introduction: Fatty liver disease (FLD) is
correlated with cardiovascular disease. Carotid intima–media thickness (CIMT)
and coronary artery calcium score (CACS) can noninvasively identify subclinical
atherosclerosis and predict risk for cardiovascular events. This study evaluated
CIMT and CACS measurements to detect subclinical atherosclerosis in patients
with and without FLD.
Methods: Patients who underwent carotid and abdominal ultrasounds as well as
cardiac computed tomography (CT) scans were evaluated retrospectively. The
differences between the mean CIMT value and CACS measurements in patients with
FLD and those with normal livers were estimated.
Results: Among 819 patients (average age of 53.3 ± 11.2 years), 330 had FLD. The
CIMT was greater in patients with FLD compared to the controls (0.79 ± 0.17 vs
0.76 ± 0.17 mm, p = 0.012), and carotid plaques were more commonly seen in
patients with FLD. The incidence of a composite of larger CIMT (≥ 75th
percentile) plus plaque presence was higher in FLD patients (43.3 vs 36.0%, p =
0.041). Particularly among young patients (≤ 50), the CIMT was larger in
patients with FLD than in the controls. FLD increased the risk of a composite of
large CIMT plus plaque presence in young patients (odds ratio 1.92, 95%
confidence interval 1.05–3.49, p = 0.034). However, patients with FLD had no
greater incidence of CACS of over 100 than the controls.
Conclusion: CIMT was a better marker of underlying subclinical atherosclerotic
risk among patients with FLD than CACS. FLD particularly, increases the risk of
subclinical atherosclerosis in patients younger than 50 years of age. These
patients should undergo screening CIMT to detect atherosclerosis and modify risk
factors.
Title: Participation in research improves overall patient
management: insights from the Global Rheumatic Heart Disease registry (REMEDY) Authors: EA Prendergast, S Perkins, ME
Engel, B Cupido, V Francis, A Joachim, M Al Kebsi, F Bode-Thomas, A Damasceno, A
Abul Fadl, A El Sayed, B Gitura, N Kennedy, A Ibrahim, J Mucumbitsi, AM Adeoye,
J Musuku, E Okello, T Olunuga, S Sheta, BM Mayosi, LJ Zühlke, for the REMEDY
investigators
From: Cardiovascular Journal of Africa, Vol 29,
Issue 2, March/April
Published: 2018
Pages: 98–105
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2017-054
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2017-054
Background: Rheumatic heart disease (RHD) is a
major public health problem in low- and middle-income countries (LMICs), with a
paucity of high-quality trial data to improve patient outcomes. Investigators
felt that involvement in a recent large, observational RHD study impacted
positively on their practice, but this was poorly defined.
Aim: The purpose of this study was to document the experience of investigators
and research team members from LMICs who participated in a prospective,
multi-centre study, the global Rheumatic Heart Disease Registry (REMEDY),
conducted in 25 centres in 14 countries from 2010 to 2012.
Methods: We conducted an online survey of site personnel to identify and
quantify their experiences. Telephone interviews were conducted with a subset of
respondents to gather additional qualitative data. We asked about their
experiences, positive and negative, and about any changes in RHD management
practices resulting from their participation in REMEDY as a registry site.
Results: The majority of respondents in both the survey and telephone interviews
indicated that participation as a registry site improved their management of RHD
patients. Administrative changes included increased attention to follow-up
appointments and details in patient records. Clinical changes included increased
use of penicillin prophylaxis, and more frequent INR monitoring and
contraceptive counselling.
Conclusions: Our study demonstrates that participation in clinical research on
RHD can have a positive impact on patient management. Furthermore, REMEDY has
led to increased patient awareness and improved healthcare workers’ knowledge
and efficiency in caring for RHD patients.
Title: Prevalence of cardiometabolic
risk factors among professional male
long-distance bus drivers in Lagos, south-west
Nigeria: a cross-sectional study Authors: Casmir E Amadi, Tim P Grove,
Amam C Mbakwem, Obianuju B Ozoh, Oyewole A
Kushimo, David A Wood, Michael Akinkunmi
From: Cardiovascular Journal of Africa, Vol 29,
Issue 2, March/April
Published: 2018
Pages: 106–114
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-006
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-006
Background: Professional drivers are known to be
at high risk of cardiovascular disease (CVD).
This study was carried out to highlight these
risk factors and their predictors among male
long-distance professional bus drivers in Lagos,
southwest Nigeria, with a view to improving
health awareness in this group.
Methods: Socio-demographic data, anthropometric
indices, blood pressure, fasting plasma blood
glucose levels and lipid and physical activity
profiles of 293 drivers were measured.
Results: Mean age of the study population was 48
± 9.7 years; 71.0 and 19.5% of the drivers used
alcohol and were smokers, respectively; and
50.9% were physically inactive. The prevalence
of overweight and obesity was 41.7 and 21.1%,
respectively, while 39.7 and 13.9% were
hypertensive and diabetic, respectively. Ninety
(31.3%) subjects had impaired fasting glucose
levels while 56.3% had dyslipidaemia. Predictors
of hypertension were age and body mass index
(BMI). BMI only was a predictor of abnormal
glucose profile.
Conclusion: Professional male long-distance bus
drivers in this study showed a high prevalence
of a cluster of risk factors for CVD.
Title: Status of cardiac arrhythmia services in Africa in 2018: a
PASCAR Sudden Cardiac Death Task Force report Authors: MA Talle, A Bonny, W Scholtz, A Chin, G Nel, KM Karaye, JB
Anzouan-Kacou, A Damasceno, YR Lubenga, MU Sani, BM Mayosi
From: Cardiovascular Journal of Africa, Vol 29,
Issue 2, March/April
Published: 2018
Pages: 115–121
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-027
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-027
Background: There is limited information on the
availability of health services to treat cardiac arrhythmias in Africa.
Methods: The Pan-African Society of Cardiology (PASCAR) Sudden Cardiac Death
Task Force conducted a survey of the burden of cardiac arrhythmias and related
services over two months (15 October to 15 December) in 2017. An electronic
questionnaire was completed by general cardiologists and electrophysiologists
working in African countries. The questionnaire focused on availability of human
resources, diagnostic tools and treatment modalities in each country.
Results: We received responses from physicians in 33 out of 55 (60%) African
countries. Limited use of basic cardiovascular drugs such as anti-arrhythmics
and anticoagulants prevails. Non-vitamin K-dependent oral anticoagulants (NOACs)
are not widely used on the continent, even in North Africa. Six (18%) of the
sub-Saharan African (SSA) countries do not have a registered cardiologist and
about one-third do not have pacemaker services. The median pacemaker
implantation rate was 2.66 per million population per country, which is 200-fold
lower than in Europe. The density of pacemaker facilities and operators in
Africa is quite low, with a median of 0.14 (0.03–6.36) centres and 0.10
(0.05–9.49) operators per million population. Less than half of the African
countries have a functional catheter laboratory with only South Africa providing
the full complement of services for cardiac arrhythmia in SSA. Overall,
countries in North Africa have better coverage, leaving more than 110 million
people in SSA without access to effective basic treatment for cardiac conduction
disturbances.
Conclusion: The lack of diagnostic and treatment services for cardiac
arrhythmias is a common scenario in the majority of SSA countries, resulting in
sub-optimal care and a subsequent high burden of premature cardiac death. There
is a need to improve the standard of care by providing essential services such
as cardiac pacemaker implantation.
Title: The aetiology of cardiovascular disease: a role for
mitochondrial DNA?
Authors: Marianne Venter, Francois H van der
Westhuizen, Joanna L Elson
From: Cardiovascular Journal of Africa, Vol
29, Issue, 2, March/April
Published: 2018
Pages:122–132
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2017-037
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2017-037
Abstract: Cardiovascular disease (CVD) is a
world-wide cause of mortality in humans and its incidence is on the rise in
Africa. In this review, we discuss the putative role of mitochondrial
dysfunction in the aetiology of CVD and consequently identify mitochondrial DNA
(mtDNA) variation as a viable genetic risk factor to be considered. We then
describe the contribution and pitfalls of several current approaches used when
investigating mtDNA in relation to complex disease. We also propose an
alternative approach, the adjusted mutational load hypothesis, which would have
greater statistical power with cohorts of moderate size, and is less likely to
be affected by population stratification. We therefore address some of the
shortcomings of the current haplogroup association approach. Finally, we discuss
the unique challenges faced by studies done on African populations, and
recommend the most viable methods to use when investigating mtDNA variation in
CVD and other common complex disease.
Title: Absolute cardiovascular risk of women using hormonal
contraception in Porto-Novo
Authors: Arnaud Sonou, Mathieu Ogoudjobi,
Philippe Mahouna Adjagba, Corine Houehanou, Richard Aniglé, Léopold Codjo,
Murielle Hounkponou, Rosaire Bognon, Salimatou Assani, Daniel Amoussou-Guénou,
Dèdonougbo Martin Houénassi
From: Cardiovascular Journal of Africa, Vol 29,
Issue, 2, March/April
Published: 2018
Pages:e1–e4
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-016
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-016
Introduction: The purpose of this work was to
determine the absolute cardiovascular risk (ACVR) of women using hormonal
contraception in Porto-Novo.
Methods: We carried out a descriptive, cross-sectional study, including women at
the time of renewal of a hormonal contraceptive method. Blood pressure, fasting
venous blood glucose level, body mass index and electrocardiographic left
ventricular hypertrophy were studied. The determination of ACVR was dual based
on the World Health Organisation (WHO/ISH) and the European Society of
Cardiology (ESC/ ESH) models.
Results: The mean age of the women was 35.3 ± 8.2 years. Blood pressure and
blood glucose levels were high in 24 and 1.5% of cases, respectively. Left
ventricular hypertrophy was present in 7.1% of cases. A high ACVR was found in
5.2% of these women, using the ESC/ESH model.
Conclusion: The occurrence of women with high ACVR in this group raises the
problem of cardiovascular eligibility to the contraceptive method used.
Title: Partial anomalous pulmonary venous connection with accessory
pulmonary veins
Authors: Vimalarani Arulselvam, Neale N Kalis,
Suad R Al Amer
From: Cardiovascular Journal of Africa, Vol 29,
Issue, 2, March/April
Published: 2018
Pages:e5–e7
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2017-022
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2017-022
Abstract: We present a case of a six-year-old
boy with complex partial anomalous pulmonary venous connections with accessory
pulmonary veins, where multi-detector computed tomography proved crucial for
accurate identification prior to planning for surgical correction.
Title: Ischaemic heart disease and pregnancy: the tale of two
stories
Authors: Mamotabo R Matshela
From: Cardiovascular Journal of Africa, Vol 29,
Issue, 2, March/April
Published: 2018
Pages:e8–e12
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2017-050
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2017-050
Abstract: Ischaemic heart disease (IHD) is
presumed to be rare in pregnancy. Based on that assumption, patients go
undiagnosed or undertreated. IHD in pregnancy frequently occurs as a result of
an unusual aetiology, therefore each patient needs to be managed individually
since each may present differently. This may pose challenges to the consulting
clinician. Pregnancy itself is a risk factor for cardiovascular disease, due to
its associated hypercoagulable state. From current reports, the prevalence of
IHD in females is increasing due to lifestyle changes, including cigarette
smoking, diabetes and stress. In our modern societies, women delay childbearing
until they are older, allowing time for risk factors to cluster. Although
presumed to be rare in pregnant women, IHD is currently estimated to occur three
to four times more often during pregnancy in middle- and high-income women,
warranting an extensive review highlighting cases of IHD in pregnancy.